Amarin Corp Plc (AMRN)

[HDGabor]

Let me some thought (without medical background):

- expected event rate in R-IT placebo group is 5,2% / year
- we know that the event rate was around 1% / year in Jelis (without or with low dose of statin) - 80% lower than R-IT placebo group
- it looks like that statin does not decrease AA/EPA ratio (based on the citied study it increase)
- EPA decrease AA/EPA ratio significantly

I do not say that we will see the same event rate in R-IT Vascepa arm, but I believe the group will be 'transformed' to Japanese and the eff.% could be around 40%